Gene/Protein Disease Symptom Drug Enzyme Compound
Pivot Concepts:   Target Concepts:
Query: UMLS:C0432222 (SEM)
 47,337 document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)

Poly(lactic acid) microspheres with different surface charges have been prepared by using cationic, anionic or nonionic surfactants as the microspheres' surface stabilizers. Embedded with these microspheres, the modified PLA membranes with different surface charges have been obtained. The test of stability by CLSM and the morphological test by SEM confirmed that we obtained the microspheres modified PLA membranes with different surface charges successfully. The chondrocyte compatibility test of these modified PLA membranes showed that the attachment, proliferation and activity of chondrocytes on the positive surface of the modified PLA were better than those of other modified PLA membranes. The positive charge on the surface of PLA membrane could improve the cell-compatibility of PLA well.
 ...
PMID:[A study on cytocompatibility of poly (lactic acid) membrane modified by polymer microspheres with different surface charges]. 1629 32

Uniform stereo-complex microparticles ranging from nanometer to micrometer size are prepared by using stereo multiblock co-poly(rac-lactide)s (smb-PLAs) with different stereo-regularity. At comparable molecular weights, as the smb-PLA stereo-regularity decreases from 88% to 76%, the crystallinity of the microparticles decreases noticeably, as proved by DSC and WAXD. At the same time, the shape of the microparticles varies from the flower shape to the sphere shape and the particle size increases markedly from 700-2700 nm as shown by SEM. However, all insulin-loaded microparticles are of cake-shape and their sizes depend on the stereo-regularity. The crystallization of smb-PLAs facilitated by insulin is evidenced by the increase of T(m) and DeltaH(f) in DSC. The highest insulin-loading content of 14.2% and -entrapment efficiency of 82.8% are obtained from the smb-PLA with the highest stereo-regularity of 88%. Release studies in vitro show the least first-day release at about 25% followed by continuous release of another 70% of insulin over one month. Stereo-complex microparticles of smb-PLAs with lower stereo-regularity resulted in a relatively lower insulin-entrapment efficiency and -loading content, a larger first-day release, and also complete release of 90% of the total amount within one month. The release system follows a diffusion mechanism. By contrast, atactic PLA shows a very low entrapment efficiency of 16.7%. Structure of a stereo multiblock co-poly(rac-lactide).
 ...
PMID:Effects of stereo-regularity of multiblock co-poly(rac-lactide)s on stereo-complex microparticles and their insulin delivery. 1630 90

To investigate the effect of three kinds of polymeric scaffolds on attachment, proliferation and differentiation of bone marrow mesenchymal stem cells, the cells were different polymeric scaffolds of PLA-PEG, PLA, PLGA, respectively. The proliferation of cell was evaluated by cell count; the attachment and morphology of BMSCs were observed by SEM; and differentiation was detected by alkaline phosphatase activity, fluorescence, and RT-PCR methods. Results showed that the cells in PLGA group spread better among BMSCs adhered to the three polymeric scaffolds. The activity of ALP was detected after 3 days culture in these three groups. There were no significant differences between PLA-PEG and PLGA groups, but the activity of ALP was higher than PLA group. The gene expressions of osteocalicin and collagen I were also observed in the early culture time. Calcium nodes formation in these polymeric scaffolds were detected. BMSC spreading first, then overlapping growth and secretion of matrix around the bottom and surface of scaffolds were observed through SEM. In summary, PLA-PEG and PLGA are better polymeric scaffolds for the bone tissue engineering, compared with PLA.
 ...
PMID:[Effect of polymeric scaffolds on attachment and growth of bone marrow mesenchymal stem cells]. 1642 95

Nanofibers have recently gained substantial interest for potential applications in tissue engineering. The objective of this study was to determine whether electrospun nanofibers accommodate the viability, growth, and differentiation of human mesenchymal stem cells (hMSCs) as well as their osteogenic (hMSC-Ob) and chondrogenic (hMSC-Ch) derivatives. Poly(d,l-lactide-co-glycolide) (PLGA) beads with a PLA:PGA ratio of 85:15 were electrospun into non-woven fibers with an average diameter of 760+/-210 nm. The average Young's modulus of electrospun PLGA nanofibers was 42+/-26 kPa, per nanoindentation with atomic force microscopy (AFM). Human MSCs were seeded 1-4 weeks at a density of 2 x 10(6)cells/mL in PLGA nanofiber sheets. After 2 week culture on PLGA nanofiber scaffold, hMSCs remained as precursors upon immunoblotting with hKL12 antibody. SEM taken up to 7 days after cell seeding revealed that hMSCs, hMSC-Ob and hMSC-Ch apparently attached to PLGA nanofibers. The overwhelming majority of hMSCs was viable and proliferating in PLGA nanofiber scaffolds up to the tested 14 days, as assayed live/dead tests, DNA assay and BrdU. In a separate experiment, hMSCs seeded in PLGA nanofiber scaffolds were differentiated into chodrogenic and osteogenic cells. Histological assays revealed that hMSCs continuously differentiated into chondrogenic cells and osteogenic cells after 2 week incubation in PLGA nanofibers. Taken together, these data represent an original investigation of continuous differentiation of hMSCs into chondrogenic and osteogenic cells in PLGA nanofiber scaffold. Consistent with previous work, these findings also suggest that nanofibers may serve as accommodative milieu for not only hMSCs, but also as a 3D carrier vehicle for lineage specific cells.
 ...
PMID:Continuing differentiation of human mesenchymal stem cells and induced chondrogenic and osteogenic lineages in electrospun PLGA nanofiber scaffold. 1701 Apr 25

The purpose of this work was to study the effect of organic solvent and surfactant type on the in vitro release behavior in general and on the burst release in particular of beta-estradiol from PLA/PLGA microspheres. Also the effect of these variables on the encapsulation efficiency was investigated. The microspheres were prepared by solvent evaporation technique using dichloromethane (DCM), ethyl acetate (EtAc), tetrahydrofuran (THF), chloroform (CHCl3) or acetone (AC) as organic solvent and polyvinyl alcohol (PVA), Tween 80, sodium lauryl sulfate (SLS) or benzalkonium chloride (BKCI) as surfactant. The obtained microspheres were tested for encapsulation efficiency and in vitro drug release using 50% methanol/buffer pH 7.4 as dissolution medium. EtAC and PVA formulations showed the highest encapsulation efficiency and the lowest burst release. These microspheres were further characterized for particle size distribution, SEM and zeta potential. The results suggested that these materials could be starting materials to prepare a beta-estradiol biodegradable controlled delivery system.
 ...
PMID:beta-Estradiol biodegradable microspheres: effect of formulation parameters on encapsulation efficiency and in vitro release. 1702 Jan 54

We have investigated the degradation of pure Polycaprolactone (PurePCL) and chitin short fiber reinforced Polycaprolactone composite (SFRP) in vitro in order to provide useful scientific basis for clinical application. PurePCL, SFRP and DL-PLA were immersed in 0.9% NaCL solution for periods of 2, 4, 8, 12, 16 and 24 weeks. Then pH values in immersing solution, weight loss and mechanical properties of tested materials were measured and SEM was used to study the change of the materials in the process of degradation. It was shown that the initial strength of SFRP was much higher than that of PurePCL. In the process of degradation of SFRP, the pH values maintained weak acid or remianed neutral. The rate of weight loss of SFRP was faster than that of PurePCL, but slower than that of DL-PLA. The strength and modulus of SFRP did not change much in 24 weeks, compared with the initial ones. In conclusion, the composites have excellent properties and may be optimal for clinical use in reconstruction of chest wall defects as well as in internal fixation of bone fracture.
 ...
PMID:[The degradation performance of chitin short fiber reinforced polycaprolactone composite in vitro]. 1771 66

Poly(lactic acid) (PLA) was modified by maleic anhydride (MAH), then the resultant MAH modified PLA (MPLA) was acylated with ethylenediamine (EDA), so EDA-MAH modified PLA (EMPLA) was prepared. The results of DSC, FT-IR and NMR testified that MAH and EAD were successfully introduced into the original polymer. The hydrophilicity of EMPLA was considerably increased compared with that of PLA. The degradation experiment showed that the introduction of EDA into the original polymer could neutralize the carboxyl end groups of the degradation products. The results of SEM and MTT of rat osteoblasts cultured in vitro showed that the cytocompatibility and cell adhesion of the modified materials were significantly increased compared with the original polymer, especially EMPLA; the number of cells were obviously increased and cells attached firmly to the material; these were ascribed to the EDA neutralizing the carboxyl end groups of the degradation products.
 ...
PMID:Two-step modification of poly(D, L-lactic acid) by ethylenediamine-maleic anhydride. 1845 89

Biocompatibility of PLLA and stereocomplexed PLA nanofibers was evaluated by subcutaneous implantation in rats for 4-12 weeks. Characterization of the nanofibers was performed by GPC, SEM, wide-angle X-ray diffraction, and optical microscopy of hematoxylin-eosin stained ultrathin sections of explanted nanofibers. Stereocomplexed PLA nanofiber showed slower degradation than PLLA nanofiber and thus retained their shape after prolonged implantation. Furthermore, stereocomplexed PLA nanofiber caused milder inflammatory reaction than PLLA nanofiber. These results offer the potential use of PLLA and stereocomplexed PLA nanofibers as a biomaterial for short-term and long-term tissue regeneration, respectively. Stereocomplexed PLA nanofiber after in vitro degradation showed smaller degree of swelling than PLLA nanofiber. Taking the results of in vivo degradation together with in vitro degradation into consideration, bioabsorption mechanism of the in vivo degradation of the nanofibers is proposed.
 ...
PMID:In vivo tissue response and degradation behavior of PLLA and stereocomplexed PLA nanofibers. 1911 3

The objective of this study was to assess the efficacy of a subcutaneous melatonin implant to suppress estrus in queens (felis catus). The hypothesis was that this implant would temporarily and reversibly suppress estrus in queens without producing any clinically detectable side effects. Fourteen adult queens were maintained in cages under artificial illumination (14h light:10h dark) for 45 d and then randomly assigned to one of two treatments. At interestrus, queens received a single subcutaneous melatonin implant (18mg; Melovine [CEVA Sante Animal, Libourne, France]; MEL: n=9), or a single subcutaneous placebo implant without melatonin (0mg; PLA; n=5). At the next estrus, all queens received a second MEL (n=9) or PLA (n=5) implant. Blood samples were taken when queens displayed estrous signs and during interestrus to measure estradiol (E(2)) and progesterone (P(4)), respectively, by radioimmunoassay. There were no significant differences in duration of the interestrus interval in PLA cats, regardless of whether the implants were placed during interestrus or estrus (6.0+/-9.7 d vs. 6.0+/-9.7 d, respectively; least square means [LSM]+/-SEM). However, when MEL implants were placed during interestrus, the duration of interestrus was approximately twice as long as that occurring when MEL implants were placed during estrus (113.3+/-6.1 d vs. 61.1+/-6.8 d, respectively; P<0.01). Serum E(2) and P(4) concentrations were similar in queens with PLA and MEL implants and in queens that received implants in estrus and interestrus. In conclusion, a subcutaneous MEL implant effectively and reversibly suppressed estrus in queens for approximately 2 to 4 mo with no clinically detectable side effects.
 ...
PMID:Suppression of estrus in cats with melatonin implants. 1953 33

In this study, a tubular scaffold composed of polylactide fibers (outside layer) and silk fibroin-gelatin fibers (inner layer) was fabricated successfully by electrospinning. Morphological, biomechanical, and dissolvable properties of the composite scaffolds were examined, in particular, biocompatibility of the scaffolds were evaluated in vitro and in vivo by means of cell culture and subcutaneous implantation test. The PLA/SF-gelatin tubular scaffolds, with porosity of approximately 82 +/- 2%, possessed appropriate breaking strength (2.21 +/- 0.18 MPa), pliability (60.58 +/- 1.23%), and suture retention strength (4.58 +/- 0.62 N). The burst pressure strength of the composite scaffolds reached 1596 +/- 20 mmHg, which is much greater than that of the native vessels. The composite scaffolds could hardly dissolve in the water; the water-dissolved rate was only 0.3 +/- 0.1%. MTT assay and SEM observation indicated that both 3T3 mouse fibroblasts and human umbilical vein endothelial cells could adhere, spread, and proliferate well on the composite tubular scaffolds after culturing for 14 and 21 days, respectively. The subcutaneous implantation results showed that macrophages and lymphocytes were not observed, which indicated that the composite scaffolds could induce minor inflammatory reactions in vivo. The PLA/SF-gelatin tubular scaffolds are biocompatible, possess appropriate biomechanical properties, and provide a favorable environment that supports the growth of cells, which shows that the composite tube can be considered as an ideal candidate for tissue engineering blood vessel.
 ...
PMID:Fabrication and properties of the electrospun polylactide/silk fibroin-gelatin composite tubular scaffold. 1972 59


<< Previous 1 2 3 4 5 6 7 8 9 10 Next >>